GHK-CU

A GHK-Cu injection is a method of systemically delivering the naturally occurring copper peptide Glycyl-L-Histidyl-L-Lysine Copper complex into the body to potentially promote tissue regeneration, wound healing, and anti-aging effects. This form of administration offers higher bioavailability compared to topical creams or serums.

Function and Benefits:
GHK-Cu is a tripeptide that has a strong affinity for copper (Cu) ions, which are essential cofactors for various enzymes involved in skin and tissue health. As the body's natural GHK levels decline with age, supplementation is used to restore them to more youthful levels.

Potential benefits associated with GHK-Cu injections (mostly supported by animal/lab studies and anecdotal evidence from clinics) include:
--Skin Rejuvenation: Stimulates the production of collagen and elastin, improving skin firmness, elasticity, and clarity while reducing fine lines, wrinkles, and hyperpigmentation.
--Wound and Scar Healing: Accelerates wound closure and improves the remodeling of tissue, which can minimize scar formation, especially in cases of burns or post-surgical recovery.
--Hair Growth: Promotes hair follicle regeneration, extends the hair growth (anagen) phase, and improves blood circulation to the scalp, which can lead to thicker, denser hair.
--Anti-inflammatory and Antioxidant Effects: Helps protect cells from oxidative stress and reduces inflammation, creating an optimal environment for healing and cellular repair.
--Gene Modulation: Research indicates GHK-Cu can modulate the expression of over 4,000 human genes, essentially "resetting" cellular function to a healthier state.

Usage and Safety Considerations
--Regulatory Status: In the United States, injectable GHK-Cu is not an FDA-approved drug and is considered high-risk by the agency due to a lack of large-scale human clinical trial data for systemic use. It is typically available only by prescription from compounding pharmacies for off-label use under medical supervision.
--Administration: GHK-Cu is generally administered as a subcutaneous (SubQ) injection using an insulin syringe, often 2-3 times per week, with the injection sites rotated.
--Potential Side Effects: Side effects are usually mild and may include temporary redness, swelling, or bruising at the injection site. Systemic issues are rare at recommended doses, but individuals with copper metabolism disorders (like Wilson's disease) or active cancer should avoid use.
--Professional Guidance: Due to its unapproved status for injection, it is crucial to use only high-quality, pharmaceutical-grade peptides under the guidance of a qualified healthcare professional who can monitor progress and potential side effects.